Tuberous sclerosis complex: Genetics to pathogenesis

Pediatric Neurology

Volumn 29, Issue 5, 2003, Pages 404-409

  Narayanan, Vinodh ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAMARTIN; S6 KINASE; TARGET OF RAPAMYCIN KINASE; TUBERIN;

CELL CYCLE; CELL STRUCTURE; CYTOSKELETON; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 0347626243     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2003.09.002     Document Type: Review

References (30)

1. Gomez M.R. History of tuberous sclerosis complex. Gomez M.R., Sampson J.R., Whittemore V.H. Tuberous sclerosis complex. 3rd ed. 1999;3-9 Oxford University Press, New York.
2. Cheadle J.P., Reeve M.P., Sampson J.R., Kwiatkowski D.J. Molecular genetic advances in tuberous sclerosis. Hum Genet. 107:2000;97-114.
3. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference Revised clinical diagnostic criteria . J Child Neurol. 13:1998;624-628.
4. Fryer A.E., Chalmers A., Connor J.M., et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet. 1:1987;659-661.
5. van Slegtenhorst M., de Hoogt R., Hermans C., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:1997;805-808.
6. Kandt R.S., Haines J.L., Smith M., et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet. 2:1992;37-41.
7. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 75:1993;1305-1315.
8. Brook-Carter P.T., Peral B., Ward C.J., et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat Genet. 8:1994;328-332.
9. Green A.J., Smith M., Yates J.R.W. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 6:1994;193-196.
10. Henske E.P., Scheithauer B.W., Short M.P., et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet. 59:1996;400-406.
11. Au K.S., Hebert A.A., Roach E.S., Northrup H. Complete inactivation of the TSC product tuberin leads to formation of hamartomas. Am J Hum Genet. 65:1999;1790-1795.
12. Green A.J., Sepp T., Yates J.R. Clonality of tuberous sclerosis hamartomas shown by non-random X-chromosome inactivation. Human Genetics. 97:1996;240-243.
13. Niida Y., Stemmer-Rachamimov A.O., Logrip M., et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet. 69:2001;493-503.
14. van Slegtenhorst M., Nellist M., Nagelkerken B., et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet. 7:1998;1053-1057.
15. Benvenuto G., Li S., Brown S.J., et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 19:2000;6306-6316.
16. Potter C.J., Huang H., Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 105:2001;357-368.
17. Aicher L.D., Campbell J.S., Yeung R.S. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J Biol Chem. 276:2001;21017-21021.
18. Miloloza A., Rosner M., Nellist M., Halley D., Bernaschek G., Hengstschlager M. The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet. 9:2000;1721-1727.
19. Miloloza A., Kubista M., Rosner M., Hengstschlager M. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation. J Neuropath Exptl Neurol. 61:2002;154-163.
20. Tapon N., Ito N., Dickson B.J., Teisman J.E., Hariharan I.K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and proliferation. Cell. 105:2001;345-355.
21. Wienecke R., Konig, A., DeClue J.E. Identification of tuberin, the tuberous sclerosis-2 product Tuberin possesses specific Rap1GAP activity . J Biol Chem. 270:1995;16409-16414.
22. Xiao G.-H., Shoarinejad F., Jin F., Golemis E.A., Yeung R.S. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem. 272:1997;6097-6100.
23. Lamb R.F., Roy C., Diefenbach T.J., et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nature Cell Biology. 2:2000;281-287.
24. Haddad L.A., Smith N., Bowser M., et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J Biol Chem. 277:2002;44180-44186.
25. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell. 103:2000;253-262.
26. Inoki K., Li Y., Zhu T., Wu J., Guan K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4:2002;648-657.
27. Tee A.R., Fingar D.C., Manning B.D., Kwiatkowski D.J., Cantley L.C., Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. PNAS USA. 99:2002;13571-13576.
28. Potter C.J., Pedraza L.G., Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biol. 4:2002;658-665.
29. McMannus E.J., Alessi D.R. TSC1-TSC2 A complex tale of PKB-mediated S6K regulation . Nature Cell Biol. 4:2002;E214-216.
30. Kwiatkowski D.J. Tuberous sclerosis From tubers to mTOR . Ann Hum Genet. 67:2003;87-96.